These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 1873503)

  • 1. Construction of reshaped human antibodies with HIV-neutralizing activity.
    Maeda H; Matsushita S; Eda Y; Kimachi K; Tokiyoshi S; Bendig MM
    Hum Antibodies Hybridomas; 1991 Jul; 2(3):124-34. PubMed ID: 1873503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1.
    Major JG; Liou RS; Sun LK; Yu LM; Starnes SM; Fung MS; Chang TW; Chang NT
    Hum Antibodies Hybridomas; 1994; 5(1-2):9-17. PubMed ID: 7858187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-idiotypic antibodies to the third variable domain of gp120 induce an anti-HIV-1 antibody response in mice.
    Boudet F; Theze J; Zouali M
    Virology; 1994 Apr; 200(1):176-88. PubMed ID: 7510435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity.
    Thompson J; Pope T; Tung JS; Chan C; Hollis G; Mark G; Johnson KS
    J Mol Biol; 1996 Feb; 256(1):77-88. PubMed ID: 8609615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
    D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G
    AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of heavy chain constant regions on antigen binding and HIV-1 neutralization by a human monoclonal antibody.
    Cavacini LA; Emes CL; Power J; Desharnais FD; Duval M; Montefiori D; Posner MR
    J Immunol; 1995 Oct; 155(7):3638-44. PubMed ID: 7561063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120.
    Gorny MK; Xu JY; Karwowska S; Buchbinder A; Zolla-Pazner S
    J Immunol; 1993 Jan; 150(2):635-43. PubMed ID: 7678279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization.
    Back NK; Smit L; De Jong JJ; Keulen W; Schutten M; Goudsmit J; Tersmette M
    Virology; 1994 Mar; 199(2):431-8. PubMed ID: 8122371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection and characterization of an HIV-1 gp120-binding affibody ligand.
    Wikman M; Rowcliffe E; Friedman M; Henning P; Lindholm L; Olofsson S; Ståhl S
    Biotechnol Appl Biochem; 2006 Sep; 45(Pt 2):93-105. PubMed ID: 16712522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation.
    Kettleborough CA; Saldanha J; Heath VJ; Morrison CJ; Bendig MM
    Protein Eng; 1991 Oct; 4(7):773-83. PubMed ID: 1798701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, expression, and characterization of a multivalent, combination HIV microbicide.
    Sexton A; Harman S; Shattock RJ; Ma JK
    FASEB J; 2009 Oct; 23(10):3590-600. PubMed ID: 19470798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virolysis and in vitro neutralization of HIV-1 by humanized monoclonal antibody hNM-01.
    Nakamura M; Terada M; Sasaki H; Kamada M; Ohno T
    Hybridoma; 2000 Dec; 19(6):427-34. PubMed ID: 11152394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanization of a mouse anti-human interleukin-6 receptor antibody comparing two methods for selecting human framework regions.
    Sato K; Tsuchiya M; Saldanha J; Koishihara Y; Ohsugi Y; Kishimoto T; Bendig MM
    Mol Immunol; 1994 Apr; 31(5):371-81. PubMed ID: 8152440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A humanized anti-tumor necrosis factor-alpha monoclonal antibody that acts as a partial, competitive antagonist of the template antibody.
    Tempest PR; Barbanti E; Bremner P; Carr FJ; Ghislieri M; Rifaldi B; Marcucci F
    Hybridoma; 1994 Jun; 13(3):183-90. PubMed ID: 7927362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient generation of a reshaped human mAb specific for the alpha toxin of Clostridium perfringens.
    Tempest PR; White P; Williamson ED; Titball RW; Kelly DC; Kemp GJ; Gray PM; Forster SJ; Carr FJ; Harris WJ
    Protein Eng; 1994 Dec; 7(12):1501-7. PubMed ID: 7716162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction and clinical application of chimeric antibodies].
    Kuroki M; Arakawa F; Haruno M
    Nihon Rinsho; 1995 Dec; 53(12):3122-31. PubMed ID: 8577069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human monoclonal antibodies: recent achievements.
    Burton DR; Barbas CF
    Hosp Pract (Off Ed); 1994 Nov; 29(11):111, 114-6, 119 passim. PubMed ID: 7962228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A self shaped and reshaped: the statue within.
    Stent GS
    Science; 1988 Mar; 239(4847):1545-6. PubMed ID: 17772753
    [No Abstract]   [Full Text] [Related]  

  • 20. Preface How Molecular Genetics Has Reshaped Clinical Electrophysiology-From an Historical Perspective to the New Challenges.
    Priori SG
    Card Electrophysiol Clin; 2010 Dec; 2(4):xv-xvii. PubMed ID: 28770726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.